Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537198 | Vaccine | 2017 | 8 Pages |
Abstract
Our results suggest that MF59-TIV is effective in reducing several influenza-related outcomes among the elderly, especially hospitalizations due to influenza-related complications.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alexander Domnich, Lucia Arata, Daniela Amicizia, Joan Puig-Barberà , Roberto Gasparini, Donatella Panatto,